[Summary of Presentation]
Date and time: Friday, November 22, 2024 13:40 to 15:10
General oral presentation 6 Medical data analysis 1
Conceptual demonstration of historical Cal cohort research based on electronic medical record information of multiple medical institutions collected under the Next Generation Medical Infrastructure Act
Yosuke Nishida^*1, Taku Nozue^*1, Shinsuke Kurosu^*2, Fumiki Oba^*2, Yukinori Sakata^*3, Mie Azuma^*3, Rika Abe^*4, Aki Hasegawa^*5, Rika Okamoto^*6, NAKAGAMI Yuki^*7,8, Yasushi Okuno^*4, Masahiko Naka, ^9, 8, Masahiko Naka, 9, 0 *

^**2 EA Pharma Co., Ltd., ^*3 Eisai Co., Ltd., ^*4 RIKEN, ^*5 Kyoto University Graduate School of Medicine, ^*6 Kobe Medical and Cities Promotion Organization Medical Innovation Promotion Center, ^Shimonoseki City University Faculty of Data Science, ^*8 Yamaguchi University Graduate School of Medicine, *9 Yamaguchi University School of Medicine, ^Yamaguchi University Hospital

[Contents of presentation]
In Japan, new drugs are increasingly approved based on the results of international joint trials, but domestic data is limited and issues remain in cost-effective analysis and drug selection in clinical practice. As one way to solve such problems, it should be possible to quickly create domestic evidence by utilizing electronic medical record data collected by opt-out by medical institutions authorized by the Next Generation Medical Funds Act. We conducted a proof-of-concept test of atezolizumab and examined the feasibility of rapid efficacy evaluation using electronic medical record information of multiple medical institutions under the Next Generation Medical Infrastructure Act.

[Overview of the Society]
Society name: The 44th Association of Medical Informatics (25th Annual Meeting of the Japan Society of Medical Informatics)
Theme: New Future of Digital Health
Date: November 21 (Thu)-24 (Sun), 2024
Venue: Fukuoka Sun Palace, Fukuoka International Convention Center
URL　：https://jcmi44.org/

[Contact]
Public university corporation Shimonoseki City University
Corporate Planning Department Public Relations and Branding Strategy Division
TEL. 083-253-8967